Benzinga · Oct 26, 2026
TD Cowen Maintains Buy on Establishment Labs Hldgs, Lowers Price Target to $95
TD Cowen analyst Joshua Jennings maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and lowers the price target from $117 to $95.
ES
NASDAQ · ESTA
Establishment Labs Holdings Inc.
Healthcare · Medical - Devices
$62.46
Down-$5.95 (-8.70%)
Updated Nov 1, 2026, 9:29 PM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.11B
- P/E ratio
- -25.93
- Dividend yield
- 0.00%
- 52-week range
- $47.00 – $97.59
- Volume
- 1.03M
- Avg. volume
- 456.66K
Price performance · ESTA
ESTA price history
1M range · 0 trading sessions · Daily adjusted prices
ESTA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest ESTA news
The latest Smart Investors Daily articles mentioning ESTA.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ESTA research
Overview
Company profile and research snapshot.
Company profile
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $82.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 29, 2026 | BTIG | Buy | — |
| Oct 26, 2026 | TD Cowen | Buy | — |
| Oct 15, 2026 | TD Cowen | Buy | — |
| Sep 1, 2026 | BTIG | Buy | — |
| Aug 13, 2026 | Citigroup | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 22, 2026
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Should You Buy?
Establishment Labs (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Yahoo · Oct 19, 2026
Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29
NEW YORK, October 19, 2026--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2026, before the market opens on Thursday, October 29, 2026, and will host a conference call at 8:30 AM ET that day to discuss those results.
Benzinga · Oct 15, 2026
TD Cowen Reiterates Buy on Establishment Labs Hldgs, Maintains $117 Price Target
TD Cowen analyst Joshua Jennings reiterates Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and maintains $117 price target.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
